CTOs on the Move

Femasys

www.femasys.com

 
Our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. The pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. The team is complemented by world-class medical advisors. Our products have been organically conceived, researched and developed by the Company and all manufacturing activities are conducted to ensure compliance with the U.S. Food and Drug Administration (FDA) per the requirements of 21 CFR 820, as well as ISO 13485. Femasys ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.femasys.com
  • 5000 Research Court Suite 100
    Suwanee, GA USA 30024
  • Phone: 770.500.3910

Executives

Name Title Contact Details

Funding

Femasys raised $10M on 05/01/2015

Similar Companies

AmMed Direct

AmMed Direct is a Antioch, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BERCHTOLD Corporation

BERCHTOLD Corporation is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pulmonx

Pulmonx is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

T2 Biosystems

At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.

FONAR Corporation

Fonar Corporation (Fonar) operates in two business segments: medical equipment segment, and physician management and diagnostic services segment. Fonar is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance